These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34896194)

  • 21. Single- and repeat-dose toxicity of IDX14184, a nucleotide prodrug with antiviral activity for hepatitis C viral infection, in mice, rats, and monkeys.
    Luo S; Rush R; Standring D
    Hum Exp Toxicol; 2016 May; 35(5):472-90. PubMed ID: 26138064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases.
    Lansita JA; Mease KM; Qiu H; Yednock T; Sankaranarayanan S; Kramer S
    Int J Toxicol; 2017; 36(6):449-462. PubMed ID: 29202623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the acute and subchronic toxic effects in mice, rats, and monkeys of the genetically engineered and Escherichia coli cytosine deaminase gene-incorporated Salmonella strain, TAPET-CD, being developed as an antitumor agent.
    Lee KC; Zheng LM; Margitich D; Almassian B; King I
    Int J Toxicol; 2001; 20(4):207-17. PubMed ID: 11563416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetracycline delivery from fibrin controls peritoneal infection without measurable systemic antibiotic.
    Woolverton CJ; Fulton JA; Salstrom SJ; Hayslip J; Haller NA; Wildroudt ML; MacPhee M
    J Antimicrob Chemother; 2001 Dec; 48(6):861-7. PubMed ID: 11733470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
    Gad SC; Sullivan DW; Crapo JD; Spainhour CB
    Int J Toxicol; 2013 Jul; 32(4):274-87. PubMed ID: 23704100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist.
    Waites CR; Dominick MA; Sanderson TP; Schilling BE
    Toxicol Sci; 2007 Nov; 100(1):248-58. PubMed ID: 17675651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.
    Xiong YQ; Estellés A; Li L; Abdelhady W; Gonzales R; Bayer AS; Tenorio E; Leighton A; Ryser S; Kauvar LM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections.
    Hu Y; Shamaei-Tousi A; Liu Y; Coates A
    PLoS One; 2010 Jul; 5(7):e11818. PubMed ID: 20676403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSA-90 Promotes Bone Formation and Mitigates Methicillin-resistant Staphylococcus aureus Infection in a Rat Open Fracture Model.
    Mills R; Cheng TL; Mikulec K; Peacock L; Isaacs D; Genberg C; Savage PB; Little DG; Schindeler A
    Clin Orthop Relat Res; 2018 Jun; 476(6):1311-1323. PubMed ID: 29698291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions to reduce Staphylococcus aureus in the management of eczema.
    George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug safety evaluation through biomarker analysis--a toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer.
    Hsieh FY; Tengstrand E; Lee JW; Li LY; Silverman L; Riordan B; Miwa G; Milton M; Alden C; Lee F
    Toxicol Appl Pharmacol; 2007 Oct; 224(1):12-8. PubMed ID: 17681578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical pharmacokinetics, tolerability, and pharmacodynamics of metuzumab, a novel CD147 human-mouse chimeric and glycoengineered antibody.
    Zhang Z; Zhang Y; Sun Q; Feng F; Huhe M; Mi L; Chen Z
    Mol Cancer Ther; 2015 Jan; 14(1):162-73. PubMed ID: 25376611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Simple Way to Eradicate Methicillin-Resistant
    Kim TM; Park H; Lee KW; Choi EW; Moon SH; Lee YS; Cho K; Park WJ; Park JB; Kim SJ
    Comp Med; 2017 Aug; 67(4):356-359. PubMed ID: 28830583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus.
    Assis LM; Nedeljković M; Dessen A
    Drug Resist Updat; 2017 Mar; 31():1-14. PubMed ID: 28867240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly Efficient Synthesis of a Staphylococcus aureus Targeting Payload to Enable the First Antibody-Antibiotic Conjugate.
    Linghu X; Segraves NL; Abramovich I; Wong N; Müller B; Neubauer N; Fantasia S; Rieth S; Bachmann S; Jansen M; Sowell CG; Askin D; Koenig SG; Gosselin F
    Chemistry; 2018 Feb; 24(12):2837-2840. PubMed ID: 29164727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections.
    Goldmann O; Cern A; Müsken M; Rohde M; Weiss W; Barenholz Y; Medina E
    J Control Release; 2019 Dec; 316():292-301. PubMed ID: 31715276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Novel Antistaphylococcal Ectolysin P128 in a Rat Model of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Channabasappa S; Durgaiah M; Chikkamadaiah R; Kumar S; Joshi A; Sriram B
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180523
    [No Abstract]   [Full Text] [Related]  

  • 39. Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats.
    Hoover JL; Singley CM; Elefante P; DeMarsh P; Zalacain M; Rittenhouse S
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections.
    Mariathasan S; Tan MW
    Trends Mol Med; 2017 Feb; 23(2):135-149. PubMed ID: 28126271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.